May 19, 2020

Safety considerations of chloroquine and hydroxychloroquine in treatment of COVID-19

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
S GeversC van Nieuwkoop

Abstract

Chloroquine and hydroxychloroquine are both used to treat COVID-19. Safety data in this specific population is largely unknown. In particular, cardiologic, gastro-intestinal and neuropsychiatric side-effects of (hydroxychloroquine) needs special attention in COVID-19 patients.

  • References
  • Citations1

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations1

Citations

Mentioned in this Paper

Hydroxychloroquine
Gastrointestinal Tract Structure
Adverse Effects
A 19
Chloroquine

Related Feeds

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

BMJ : British Medical Journal
Robin E Ferner, Jeffrey K Aronson
European Heart Journal. Cardiovascular Pharmacotherapy
Kamalan Jeevaratnam
The Lancet Infectious Diseases
Nicola Principi, Susanna Esposito
Respirology : Official Journal of the Asian Pacific Society of Respirology
Srinadh Annangi
© 2020 Meta ULC. All rights reserved